INTRODUCTION
Chaperonin 60 (Cpn60), also known as heat-shock protein 60 (Hsp60 or GroEL), performs important functions in protein folding and cell survival in stress conditions (Fisher, 1998; Grimaud & Toussaint, 1998; Hendrix & Tsui, 1978; Horwich et al., 2006 Horwich et al., , 2007 Sigler et al., 1998; Tang et al., 2006) . One of the best-characterized Cpn60 molecular chaperones is the Escherichia coli GroE, which is composed of GroEL (60 kDa), a homo-oligomer of 14 subunits arranged into two heptameric rings forming a cylindrical structure with two large cavities, and GroES (10 kDa) forming a heptameric homo-oligomer ring (Braig et al., 1994; Saibil, 2000; Sigler et al., 1998; Xu et al., 1997) . Both GroEL and GroES are essential for protein folding under all cell growth conditions (Cheng et al., 1989; Fayet et al., 1989; Horwich et al., 1993) .
Most bacteria have only one copy of the groEL and groES genes in a single operon (Lund, 2001) , but mycobacteria are unusual in encoding more than one copy of the Cpn60 protein (Kong et al., 1993; Qamra et al., 2005) . Thus, Mycobacterium tuberculosis (Mtb) and Mycobacterium bovis BCG have two Cpn60 (Cpn60.1 and Cpn60.2) and one Cpn10 (Hsp10 or GroES) proteins. The two cpn60 genes are located distantly on the genomes, and the cpn60.1 (Rv3417c) gene is immediately downstream of cpn10 (Rv3418c) (Kong et al., 1993) . The two Cpn60 proteins are upregulated during heat shock (Stewart et al., 2002) , oxidative stress response (Dosanjh et al., 2005) and macrophage infection (Monahan et al., 2001) . In contrast with Cpn60.1, Cpn60.2 (Rv0440, also called Hsp65, Hsp60-2, GroEL-2) and Cpn10 are essential and are required for mycobacterial survival (Hu et al., 2008) . The immunological properties of Cpn60.2 have been studied extensively. Mycobacterial Cpn60.2 can facilitate efficient Mtb bacterial association with macrophages (Hickey et al., 2009) and is an immunodominant antigen that induces a strong cellular and humoral immune response (De Bruyn et al., 1987; Kaufmann et al., 1987; Kaufmann, 1990; Peetermans et al., 1994; Thole et al., 1988) . Immunization with Mtb Cpn60.2 can protect against the induction of virtually all forms of experimental arthritis in rats (Prakken et al., 2003; van Eden et al., 1988; van Eden et al., 1989) . Moreover, the potential of Cpn60.2 as a possible anticancer vaccine, alone or in combination with some tumour antigens, has been reported in many studies (Cappello et al., 2007 (Cappello et al., , 2008 Huang et al., 2007) .
Mtb Cpn60.1 can inhibit allergen-induced pulmonary eosinophilia in mice (Riffo-Vasquez et al., 2004) and it is 100-fold more potent than Cpn60.2 in inducing cytokine release from human monocytes in vitro (Lewthwaite et al., 2001) . In fact, it has been shown that Cpn60.1 can bind to approximately 90 % of circulating monocytes compared with Cpn60.2 that binds less than 50 % of these cells (Cehovin et al., 2010) . Mtb Cpn60.1 also plays a key role in the regulation of the cytokine-dependent granulomatous response in Mtb infection in mice and in guinea pigs (Hu et al., 2008) . In this report, we aim to investigate the role of Cpn60.1 on the biochemical and immunological properties of M. bovis BCG, in particular on the expression of proteins in this attenuated vaccine strain. By inactivating the cpn60.1 gene in this strain we show that Cpn60.1 is necessary for the integrity of the bacterial cell wall, which is involved in resistance to H 2 O 2 -induced stress but is not essential for its vaccine potential.
METHODS
Bacterial strains. M. bovis BCG GL2 was used as the parental (wildtype; WT) strain to construct the mutant BCG Dcpn60.1. E. coli Dh5a was used as a host strain for cloning and plasmid propagation and was grown on Luria-Bertani (LB) medium. Antibiotics used were ampicillin (100 mg ml 21 ), kanamycin (25 mg ml 21 ) and hygromycin (100 mg ml 21 ).
M. bovis BCG Dcpn60.1 mutant construction and complementation. To construct the cpn60.1 mutant, a 2628 bp PCR product containing the cpn60.1 gene and approximately 500 bp of flanking regions of the gene was amplified using the M. bovis BCG GL2 genomic DNA as the template and primers Cpn60.1 s (59-tcgaattcccctagcgtctatccttgac-39) and Cpn60.1-as (59-acgaattcacctggtaattcggacgg-39). The PCR product was cloned into the EcoRI site of pUC18 to generate pUC-cpn60.1. A cassette containing the aph gene conferring resistance to kanamycin from pYUB53 (Kalpana et al., 1991) was inserted into the BsaBI site to disrupt the cpn60.1 gene. After digesting the plasmid with EcoRI, the fragment containing cpn60.1 : : aph was integrated by means of blunt ligation into the NotI site of pPR27.XylE (Peirs et al., 2005) . The resulting plasmid was transformed into M. bovis BCG GL2 and the selection of mutants was performed as described previously (Pelicic et al., 1997) . The M. bovis BCG knockout mutant was designated Dcpn60.1. The complemented strain was constructed by using plasmid pIPX59 (Berthet et al., 1998) , a mycobacteriophage MS6-derived integrative vector containing the attP site and a hygromycin resistance marker. A 2168 bp DNA fragment containing the cpn60.1 gene and its 303 bp upstream sequence was amplified by PCR using primers cpn60.1c-s (59-atggtaccacaccgccaaggagaagccgcag-39) and cpn60.1c-as (59-ctggtaccgaacaacgcgccaaggaaatgtgtc-39), and then cloned into the KpnI site of pIPX59 to generate pIPX-cpn60.1C. This plasmid was transformed into Dcpn60.1, and hygromycin-resistant transformants (in which cpn60.1 was introduced at the attB site in BCG Dcpn60.1) were selected. The complemented strain was designated Dcpn60.1Comp.
Genomic DNA extraction and Southern blot analysis. Genomic DNA extraction was performed as described previously (Galamba et al., 2001) . The obtained genomic DNA was digested overnight with NcoI, and the fragments were separated by electrophoresis through 1 % agarose gels. Southern blot hybridizations were performed using cpn60.1 and aph probes obtained by PCR amplification using the corresponding pair of primers: cpn60.1 s (59-gttgctgtcatcaaggtgg-39) and cpn60.1-as (59-ccgacctagtcaccttgac-39); aph-s (59-ctcaccgaggcagttccatag-39) and aph-as (59-ggtagcgttgccaatgatg-39). Probes were labelled with [a-32 P]dCTP using megaprime DNA labelling systems (Amersham).
In vitro growth without stress. For cultures in liquid media, the M. bovis BCG strains were grown in 7H9 medium containing 0.05 % Tween 80 supplemented with 10 % albumin-glucose-catalase complex (Difco Laboratories) without agitation, or grown as surface pellicles on Sauton medium using glycerol as a carbon source for 10-14 days at 37 uC. For cultures on solid medium, M. bovis BCG was IP: 54.70.40.11
On: Thu, 06 Dec 2018 15:45:27 grown on 7H11 Middlebrook agar supplemented with oleic acidalbumin-glucose-catalase complex (Difco).
In vitro growth under stress conditions. The M. bovis BCG strains were grown in 7H9 medium to exponential phase for 7-8 days. A series of 20 ml cultures were used to determine c.f.u. counts after exposure to various stress conditions. For thermal stress, the cultures were incubated at 39 or 42 uC; for hydrogen peroxide stress, a final concentration of 1, 5 or 10 mM was used; for SDS stress, 0.0025 or 0.005 % SDS was applied to the tested samples; and for acidic stress, acidified 7H9 medium (pH 5) was used. Except for the cultures for thermal stress, all other cultures were incubated at 37 uC. At different times, c.f.u. in the control and stressed cultures were determined by plating on 7H11 agar solid medium. Results were expressed as percentage surviving bacteria with respect to the control. Each stress experiment was repeated three times.
Culture filtrate harvesting and pellicle wet-weight estimation.
After 10-14 days of growth on Sauton medium, the culture filtrate was recovered by filtration through a 0.22 mm filter (Nalgene) using a vacuum pump, and the pellicle was harvested and washed three times with a diluted (1/5) Sauton medium, and finally weighed.
Protein quantification. Protein concentration was determined by using the Coomassie Brillant Blue method (Spector, 1978) with the Bio-Rad reagent using BSA as standard.
Isolation of the crude outermost cell envelope components.
Isolation of the outermost cell envelope material (OCEM) was carried out as described previously (Ortalo-Magné et al., 1995) . Briefly, the surface-pellicle-grown cells were harvested by pouring off the medium and then were gently shaken for 1 min with 5 g glass beads (4 mm diameter) per 1 g wet cells. The treated overall bacterial material was collected; the beads were washed three times with 15 ml 20 mM sodium phosphate buffer pH 7.3; and all soluble fractions were pooled. After a 2 h sedimentation, the supernatant was filtered on 0.45 mm filter (Nalgene) and used for different assays.
Isocitrate dehydrogenase assay. Isocitrate dehydrogenase activity in the culture filtrate and in the cellular extract as well as in the OCEM was followed by measuring NADP reduction at 340 nm in 88 mM imidazole buffer, pH 8, containing 3.3 mM MgCl 2 and 0.4 mM NADP. The reaction was initiated by addition of DLisocitrate to a final concentration of 1 mM.
SDS-PAGE and Western blotting. SDS-PAGE was carried out as described by Laemmli (1970) . After transfer of proteins onto nitrocellulose membranes, Western blot analyses were carried out with a rat anti-KasA/KasB antibody raised against Mtb KasA (a kind gift from Dr Laurent Kremer, UMR5235, Université Montpellier II, France) or with an anti-Hsp65 monoclonal antibody (mAb) (IA1) (De Bruyn et al., 2000) . Protein bands were visualized by using alkaline phosphatase (Sigma).
Affinity chromatography using nickel-chelating agarose resin.
WT M. bovis BCG and Dcpn60.1 strains were grown as a surface pellicle at 37 uC on Sauton medium to stationary phase as described previously (De Bruyn et al., 2000) . Bacteria were harvested and suspended in 50 mM Tris, pH 7.5, 150 mM NaCl and disrupted by sonication. The lysates were centrifuged at 13 000 r.p.m. for 30 min and the supernatants were passed through a column containing 1 ml equilibrated Probond Ni 2+ -chelating agarose resin (Invitrogen). After washing with the same buffer, proteins were eluted from the column with the same buffer containing 20 or 75 mM imidazole, as described previously (Ojha et al., 2005) . The eluates were analysed by SDS-PAGE and by Western blot using anti-Hsp65 mAb and anti-KasA/B antibody.
Sample preparation for 2D gel electrophoresis (2-DE). WT M. bovis BCG, Dcpn60.1 and Dcpn60.1Comp strains were grown as a surface pellicle at 37 uC in Sauton medium to stationary phase. Bacteria were separated from the culture filtrate (CF) by filtration through a Whatman filter paper no. 1. Cells were suspended (1 g ml 21 ) in 50 mM Tris/HCl buffer, pH 7.2, 0.2 % Triton X-100, homogenized with a Dounce homogenizer, and then sonicated for 10 min. This sonicated solution was considered as the cell extract (CE). Proteins in CF were recovered by ammonium sulfate precipitation. Precipitate was extensively dialysed against 50 mM Tris/HCl buffer, pH 7.2. Protein concentrations in the CF and CE were determined by using the Bio-Rad protein Assay kit (Bio-Rad).
2-DE.
Proteins from CFs and CEs were diluted in denaturing buffer (7 M urea, 2 M thiourea, 4 % (w/v) CHAPS and 50 mM DTT) containing a complete set of protease inhibitors (Roche) and centrifuged for 20 min at 20 000 g to discard the insoluble components. The supernatant was collected, and the protein concentration was measured using the Bradford method. Iso-electric focusing (100 mg protein) was performed using immobilized pH gradient strips (18 cm; Amersham Pharmacia Biotech). The firstdimension iso-electric focusing was carried out as described previously (Noël-Georis et al., 2004) . The second dimension vertical slab SDS-PAGE (12 %) was run for 4 h at 30 mA per gel using the Protean II Xi apparatus (Bio-Rad). The gels were stained with Sypro ruby (Molecular Probes) and imaged using a Typhoon 8600 system (Amersham Biosciences), or the proteins were revealed by silver staining. 2-DE gels were then analysed by using the PDQuest 2D analysis software (V6.2; Bio-Rad).
Sample preparation for MS analysis. Gel spots were excised and separately washed and digested with modified sequencing grade trypsin (Promega), and the resulting peptides were extracted and analysed by nanoLC-MS/MS as described by Leroy et al. (2007) and Mastroleo et al. (2009) .
MALDI-TOF MS analysis. Peptides from digested proteins were solubilized in 2 ml 0.5 % trifluoroacetic acid (TFA). Peptide mass fingerprints (PMF) were obtained by using a MALDI-TOF mass spectrometer (Micromass) working in reflection mode with 15 kV source voltage, 2.5 kV pulse voltage and 2 kV reflecting voltage. A saturated solution of a-cyano-4-hydroxycinnamic acid in 50 % acetonitrile and 0.1 % TFA was used for the matrix. A total of 1 ml of the matrix and sample solution was mixed in a 1 : 1 (v/v) ratio and applied onto the 96 target wells. Mass accuracy for PMF analysis was 0.1 Da with external calibration. Internal calibration was carried out by using enzyme autolysis peaks, and the resolution was 11 000. The resulting peptide masses were automatically searched for matches, in a local copy of NCBInr database release 20080704 using an in-house Mascot 2.2 server (Matrix Science). Searches were carried out in all species with the following parameters: max. missed cleavages51; mass tolerance550 p.p.m.; fixed modifications5carbamidomethylation (C); variable modificaions5oxidation of methionines. Protein identification results were manually evaluated. Only identification results with a confidence level above 95 % were confirmed as positive hits.
MS/MS analysis. Peptides were analysed using the 'peptide scan' option of the HCT ultra ion Trap (Bruker), consisting of a full-scan MS and MS/MS scan spectrum acquisitions in ultrascan mode (26 000 m/z s 21 ). Peptide fragment mass spectra were acquired in data dependent AutoMS(2) mode with a scan range of 100-2800 m/z, three averages and four precursor ions selected from the MS scan 300-1500 m/z. Precursors were actively excluded within a 0.5 min window, and all singly charged ions were excluded. Peptide peaks were detected and deconvoluted automatically using Data Analysis 2.4 software (Bruker). Mass lists in the form of Mascot generic files were created automatically and used as the input for Mascot MS/MS ions searches of the NCBInr database release 20080704 using an in-house Mascot 2.2 server (Matrix Science). The default search parameters used were: taxonomy5none; enzyme5trypsin; max. missed cleavages51; fixed modifications5carbamidomethyl (C); variable modifications5 oxidation of methionines; peptide tolerance± 1.5 Da; MS/MS tolerance±0.5 Da; peptide charge52+ and 3+; instrument5ESI186 TRAP. Only sequences identified with a Mascot score above 50 were considered, and single peptide identification was systematically evaluated manually.
Lipid analysis. Mycobacterial cells were treated three times with mixtures of chloroform and methanol according to standard protocols (Constant et al., 2002; Rafidinarivo et al., 2009) . The organic phases were pooled, dried and weighed for quantification. In order to distinguish alkali-stable lipids, e.g. phthiocerol-dimycocerosates (DIM) and phenol glycolipids (PGL), from alkali-labile lipids, e.g. triacylglycerol, phospholipids and trehalose esters, aliquots of the crude lipid extracts were suspended in chloroform/methanol (2 : 1, v/v) and incubated at 37 uC for 60 min with an equal volume of 0.2 M NaOH solution in methanol for mild alkaline deacylation. The mixtures were neutralized with glacial acetic acid, concentrated and dissolved in CHCl 3 . The organic phases were washed with water and dried. Intact and deacylated lipids were comparatively analysed by thin-layer chromatography (TLC) in various solvent systems, mainly petrol ether/diethyl ether 9 : 1 (v/v) for DIM and CHCl 3 /CH 3 OH 9 : 1 (v/v) for PGL. Mycolic acids were isolated from delipidated cell residues or from extractable lipids by saponification, methylated by diazomethane and their purification as a-and keto-mycolates was achieved by preparative TLC with CH 2 Cl 2 as running solvent (Daffé et al., 1983) . Purified molecules were analysed by MALDI-TOF MS using the positive mode as described previously (Constant et al., 2002; Laval et al., 2001) . Spectra were acquired in reflectron mode with an Applied Biosystems 4700 Analyser mass spectrometer (Applied Biosystems, Voyager DE-STR) equipped with an Nd:YAG laser (wavelength 355 nm; pulse ,500 ps; repetition rate 200 Hz). A total of 2500 shots were accumulated, and MS data were acquired with the default calibration for the instrument.
Inoculation of mice. BALB.B10 mice (bred in the animal facilities of WIV-ISP-Site Ukkel) were inoculated intravenously in the tail vein with 10 6 c.f.u. WT M. bovis BCG, Dcpn60.1 or Dcpn60.1Comp. Bacterial replication in spleen and lungs was monitored for 3 months by plating organ homogenates on Middlebrook 7H11-OADC plates, on days 5, 30 and 90 post-vaccination, as reported previously (Tanghe et al., 2001) .
Gamma interferon (IFN-c) responses induced with WT M. bovis
BCG, Dcpn60.1 and Dcpn60.1Comp. Three months after BCG vaccination, antigen-specific IFN-c production was analysed in spleen and lung cell cultures from vaccinated mice. Spleens and lungs from three mice per group were removed aseptically and homogenized by gentle disruption in a Dounce homogenizer, and cells were adjusted to 4610 6 white blood cells ml 21 in RPMI 1640 medium (Gibco) supplemented with 10 % fetal calf serum, 5610
25 M 2-mercaptoethanol, penicillin, streptomycin, fungizone and indomethacin (1 mg ml 21 ; Sigma). Cells were stimulated with BCG CF, purified protein derivative from M. bovis, purified recombinant Ag85A (Rv3804c), purified recombinant Ag85B (Rv1886) (all four antigens at 5 mg ml
21
) or polyclonal T cell mitogen Concanavalin A (4 mg ml
) and incubated at 37 uC in round-bottom, 96-well microtitre plates in a humidified CO 2 incubator. Responses were tested on spleens from individual mice and on lung cells pooled per group. Culture supernatants were harvested after 72 h and stored frozen at 220 uC until testing.
IFN-c ELISA. IFN-c activity was quantified by sandwich ELISA using coating antibody R4-6A2 and biotinylated detection antibody XMG1.2 (both BD Pharmingen). The detection limit of the IFN-c ELISA is 5 pg ml 21 .
Mtb challenge. BCG vaccinated and naïve BALB.B10 mice were challenged 3 months after vaccination with 2610 5 c.f.u. luminescent Mtb H37Rv by the intravenous route (Tanghe et al., 2001) . Bacterial numbers in spleen and lungs were determined by luminometry at various time points after Mtb challenge in a Turner design TD 20/20 luminometer as flash emission (15 s integration time) using 1 % ndecanal (Sigma) in ethanol as substrate. In this assay, only live bacteria are enumerated because emission of light is dependent on the presence of reduced flavin mononucleotide (FMNH 2 ), a co-factor that is only found in living cells. For statistical analysis (one-way ANOVA, Tukey's Multiple Comparison Test), results obtained in milli relative light units (RLU) per spleen or lung were converted to log 10 values.
RESULTS

Disruption of cpn60.1 and complementation
To elucidate the function of cpn60.1 in M. bovis BCG, we generated an M. bovis BCG Dcpn60.1 mutant by the allelic gene exchange method (Pelicic et al., 1997) . The cpn60.1 coding region was disrupted at its unique BsaBI site by insertion of the kanamycin-resistance aph gene excised from pYUB53 (Kalpana et al., 1991) . The selection of mutants was performed as described previously (Peirs et al., 2005) . Restriction digestion of genomic DNA by NotI and Southern blot analysis of strain Dcpn60.1 revealed a fragment of about 3.2 kb that hybridized to both cpn60.1 and aph probes, indicating that cpn60.1 was interrupted by insertion of the aph gene (Fig. 1) . 2-DE combined with MS analysis of the cellular extracts confirmed the absence of Cpn60.1 in this mutant (Fig. 1d) . To complement Dcpn60.1, the plasmid pIPX-cpn60.1C containing the cpn60.1 gene together with its 303 bp upstream sequence was transformed into Dcpn60.1, followed by selection for hygromycin resistance. The complemented strain was confirmed by PCR (data not shown) and referred to as Dcpn60.1Comp. Expression of the Cpn60.1 protein by this complemented strain was analysed and confirmed by 2-DE and MS analysis (Fig. 1d) .
Growth in liquid 7H9 and on solid 7H11 media
The WT BCG, Dcpn60.1 and Dcpn60.1Comp strains were grown in 7H9 broth. Their growth curves were monitored by both measuring the OD 600 daily and plating a series of culture dilutions on 7H11 agar plates to determine c.f.u. Growth curves in 7H9 medium were similar for the three strains ( Supplementary Fig. S1 , available with the online version of this paper), but on 7H11 agar plates, colonies of the Dcpn60.1 mutant were distinctively smaller than those of the WT and the complemented strains (Fig. 2) .
Biochemical characterization of bacterial cultures on Sauton medium
The strains were also cultured as surface pellicles on Sauton medium. All three strains were capable of forming a creased pellicle by 10-14 days, but the pellicle of the mutant was thinner than that of the two other strains ( Supplementary  Fig. S2 , available with the online version of this paper). The wild-type, mutant and complemented strains had on average (±SD) a wet weight of 5.31±0.22, 1.44±0.29 and 4.16±0.60 g per pellicle (each pellicle from 120 ml culture; average of nine independent experiments), respectively. Analysis of the culture filtrates revealed a higher protein content for the Dcpn60.1 mutant (5.96±0.63 mg per pellicle) than for the WT (1.34±0.09) and the complemented strains (3.01±0.10). The higher protein content in the CF of the mutant was not due to protein release from lysed cells because the homeostasis of bacteria had been verified by testing the isocitrate dehydrogenase activity, an intracellular marker, in both CF and CE (data not shown). When bacteria were treated mildly with glass beads to isolate the crude outermost cell envelope material (OCEM), the mutant was found to have a lower protein content (about 2.50±0.50 mg per pellicle) in the OCEM than did the WT (4.23±0.70) and the complemented strain (3.30±0.25). The increased protein content in the CF of the mutant coincided with the decrease in the OCEM, suggesting that the cell wall integrity of the mutant was impaired and that some OCEM proteins were unable to properly anchor and were released into the culture media. 
2-DE/MS analysis of the mutant compared with the WT and the complemented strain
In order to know the effect of Cpn60.1 on expression of proteins in M. bovis BCG, we performed 2-DE combined with MS analysis on CEs and CFs of the three strains grown as a surface pellicles on Sauton medium. The 2D pattern was reproducible for all CE and CF preparations, and there was a minimal variation in relative protein amounts from sample to sample. Multiple proteins were identified by using MS (see Supplementary Table S1 , available with the online version of this paper, with the respective Mb and Rv numbers). Figs 3 and 4 show the 2D patterns of whole CEs and CFs for the three strains.
Differences observed in the cellular extract of the three strains. As reported for the M. smegmatis Dcpn60.1 mutant (Ojha et al., 2005) , there were few changes in protein expression in the CE. In the Dcpn60.1 mutant Cpn60.1 was completely absent (Fig. 1d) and two proteins FadA2 and isocitrate lyase (ICL) were found to be upregulated (Fig. 3) . Since M. smegmatis Cpn60.1 modulates synthesis of mycolates of the cell wall during biofilm formation and physically associates with KasA, we analysed the spots corresponding to KasA and KasB using MS and found that there was no significant difference in expression of these proteins between the WT BCG and the Dcpn60.1 mutant (Fig. 3) . This was confirmed by Western blot of the same CE samples separated by SDS-PAGE using an anti-KasA/KasB antibody. The native Cpn60.1 contains a histidine-rich sequence at its C terminus (-DHDHHHGHAH). If a protein forms a complex with Cpn60.1 by protein-protein interaction, the complex can be retained onto Ni 2+ -chelating resin via the Cpn60.1 histidine-rich sequence. When cell extracts of WT BCG were passed through a Ni 2+ -chelating resin column, Cpn60.1, KasA and KasB proteins were recovered in the imidazole eluate. However, only a small quantity of KasB and neither KasA nor Cpn60.1 was found in the eluate of the Dcpn60.1 mutant (Fig. 3) . This suggests that Cpn60.1 of M. bovis BCG can interact physically with KasA, as previously observed in M. smegmatis (Ojha et al., 2005) . Differences observed in the culture filtrate of the three strains. In contrast to the cell extracts, major differences were observed in the composition of culture filtrates (Fig. 4,  Supplementary Table S1 ). Five proteins -Cpn60.2 (F126, F131), TB16.3 (F15), PPIase A (F16-17; iron-regulated peptidyl-prolyl cis-trans isomerase A), EF-Tu (F11-13; elongation factor thermo unstable) and EF-Ts (F127; elongation factor thermo stable) -were present in higher amounts in the CF of the Dcpn60.1 mutant. Interestingly, the well-known Hsp65 chaperonin Cpn60.2 was particularly abundant in the CF of the Cpn60.1 mutant and its amount increased about 200-fold (Fig. 5) . Except for EF-Ts, these proteins have been shown to be localized at the bacterial surface Målen et al., 2007; Rosenkrands et al., 2000a, b) . Three proteins TB22.2 (F62-63), b-1,3-glucanase (F47) and Mpt51 (F57; FbpD) were present in significantly reduced amounts while the alanine-and proline-rich protein APA (F1-2; antigen MPT-32) was absent. These four proteins are all secreted. It is noteworthy that the levels of the mycolyl-transferases Ag85A (F30-31,  F52, F54 ), Ag85B (F38) and Ag85C (F50) were comparable in the filtrates of the three strains. Functional descriptions of these proteins are provided in the Supplementary Material available with the online version of this paper.
Quantification and analysis of bacterial lipids from pellicle culture
For quantification, three independent pellicle culture samples from the WT M. bovis BCG, Dcpn60-1 mutant and complemented strains were extracted with organic solvents, i.e. chloroform and methanol, to yield extractable lipids (Constant et al., 2002) . The comparative analysis of these free lipids by TLC showed no difference concerning the ubiquitous lipids content such as triacylglycerols, phospholipids and trehalose esters. Interestingly, the absence of phthiocerol dimycocerosates in the mutant was repeatedly observed, a phenotype fully restored in the complemented strain. The resulting delipidated cells were weighed and saponified to liberate the mycolic acids covalently attached to the cell wall arabinogalactan (bound lipids). No significant differences in weight were observed among the three strains; extractable lipids and cell-wall-bound mycolates represented, respectively, 15-20 and 6-8 % of the cell dry masses of the different strains, values commonly found in mycobacteria.
Mycolic acids isolated by saponification from extractable lipids (free lipids) were methylated and compared with those prepared from delipidated cells (bound lipids) by TLC. Wild-type, mutant and complemented strains showed a similar profile, consisting of a-and ketomycolates, as expected for BCG. After purification by preparative TLC, these mycolates were analysed by MALDI-TOF MS. As shown in Fig. 6 and Table 1, all the strains contained a-mycolates corresponding to mass peaks at m/z of 1146 (C 76 ), 1174 (C 78 ), 1202 (C 80 ) and 1230 (C 82 ), and keto-mycolates corresponding to peaks at m/z 1246 (C 82 ), 1274 (C 84 ), 1302 (C 86 ) and 1330 (C 88 ). Importantly, however, the ratios of major homologues of the mycolates differed according to the strains examined. For the WT strain, the major homologue of a-mycolic acids was the C 78 -acid and the main representative of ketomycolic acids was the C 84 -acid. In contrast, for the Dcpn60.1 mutant, the main a-mycolate was the C 80 -acid (peak at m/z 1202) and the major keto-mycolate was the C 86 -acid (peak at m/z 1302). Thus, the a-and ketomycolates of the mutant possessed two carbon atoms more than those of the WT. This difference was repeatedly observed, from mycolates originating from both the bound and the extractable lipids. The phenotype of the mutant was fully restored in the complemented strain. Interestingly, this structural difference in mycolic acids was observed only when bacteria were grown as surface pellicles on Sauton medium, but not in materials from the mutant cultured in 7H9 broth (data not shown).
In vitro growth under stress conditions
In order to determine whether cpn60.1 plays a role in response to stresses, the WT and the Dcpn60.1 mutant strain were grown under different stress conditions. After exposure of the strains to 0.0025 % SDS for 48 h, the viability of both bacterial strains decreased (Fig. 7) . The Dcpn60.1 mutant seemed slightly more sensitive to SDS than did the WT, but the difference was not significant according to Student's t-test. A similar result was obtained when bacteria were stressed with 0.005 % SDS (data not shown). WT BCG was resistant to 10 mM H 2 O 2 treatment for 48 h, whereas under the same conditions, about 20 % of the mutant bacteria had died (Fig. 7) , indicating that the Dcpn60.1 mutant is more sensitive to H 2 O 2 . Neither mutant nor WT BCG was affected by the lower concentrations of 1 and 5 mM H 2 O 2 . There was no difference in viability between the WT and the mutant strain under other stress conditions, including heat (42 uC) and low pH (pH 5) (data not shown). In vivo replication of the WT M. bovis BCG, Dcpn60.1 and Dcpn60.1Comp strains As shown in Fig. 8(a) , the Dcpn60.1 mutant strain was impaired in its ability to persist in the lungs in vivo. At days 5, 30 and 90, bacterial c.f.u. numbers were 100-fold lower than those recovered from lungs of mice vaccinated with the parental WT BCG strain. Mice vaccinated with the complemented BCG strain had similar c.f.u. numbers to mice vaccinated with the WT BCG at days 5 and 30 postvaccination, whereas at day 90, c.f.u. numbers in lungs from mice vaccinated with the complemented strain were decreased compared with those in lungs from mice vaccinated with WT BCG, but were still higher than c.f.u. numbers found in mice vaccinated with the Dcpn60.1 mutant strain. In spleen (Fig. 8b) , 10-fold higher initial c.f.u. numbers were detected than in lungs following intravenous vaccination. As for the lungs, bacterial numbers of the Dcpn60.1 mutant were lower than those of the WT or complemented strain, but the differences were less pronounced in spleen.
Induction of antigen-specific IFN-c responses with the WT M. bovis BCG, Dcpn60.1 and Dcpn60.1Comp strains Comparable mycobacteria-specific IFN-c responses were detected in 72 h culture supernatant of spleen cells from mice vaccinated with the three BCG strains 3 months previously (Table 2) . IFN-c responses in lungs were undetectable at this time point (data not shown).
Protective efficacy of the WT M. bovis BCG, Dcpn60.1 and Dcpn60.1Comp strains against Mtb
The protective efficacy of the Dcpn60.1 mutant strain was compared with that of WT BCG in mice challenged with luminescent Mtb H37Rv 3 months after vaccination. As shown in Fig. 9 , the Dcpn60.1 mutant BCG conferred equal protection to parental BCG at day 20, 30, 58 and 98 postinfection both in spleen (Fig. 9a ) and in lungs (Fig. 9b) . In another experiment, the Dcpn60.1 mutant conferred equal protection against Mtb as did the complemented and the WT BCG, as assessed at weeks 4 and 12 after Mtb challenge ( Supplementary Fig. S3 , available with the online version of this paper). A long-term survival study did not show any significant difference between mice vaccinated with the WT or Dcpn60.1 strain either. Thus, the median survival time (MST) of unvaccinated, Mtb-challenged BALB.B10 mice was 20 weeks, the MST of mice vaccinated with WT BCG was 32 weeks, and the MST of mice vaccinated with Dcpn60.1 BCG was 29 weeks.
DISCUSSION
In this study, we analysed in more detail the biochemical and immunological properties of M. bovis BCG Cpn60.1 (GroEL-1). Genetic inactivation of cpn60.1 of M. bovis BCG did not significantly influence bacterial growth in 7H9 broth, but on solid 7H11 agar plates, its colonies were smaller than those of the WT parental BCG. Furthermore, mutant BCG formed a thinner surface pellicle on Sauton medium than did the WT or complemented BCG. Interestingly, the Dcpn60.1 mutant was found to be devoid of phthiocerol dimycocerosates, and its mycolates were two carbon atoms longer than those of the wild-type strain, a phenotype that was fully reversed by complementation. The different lengths of mycolates were not observed in the mutant grown in 7H9 broth, suggesting that this phenotype is directly linked to the formation of a surface pellicle. Ojha et al. (2005) have shown that in M. smegmatis, Cpn60.1 modulates the synthesis of mycolates specifically during biofilm formation and physically associates with KasA, a key component of the type II fatty acid synthase involved in mycolate synthesis (Veyron-Churlet et al., 2004) . Affinity chromatography and Western blot analyses revealed that Cpn60.1 of BCG also physically associated with KasA. In addition, we observed that KasB also interacted with Cpn60.1, a finding not reported by Ojha et al. (2005) . The phenomenon and mechanism(s) associated with the two carbon extension of the mycolates in the knock-out strain remain to be elucidated. The mycolate extension event may be linked to an association with KasB since this enzyme is responsible for the extension of mycolates to full-length (Bhatt et al., 2007; Gao et al., 2003) . For the Mtb H37Rv Dcpn60.1 mutant, Hu et al. (2008) did not use Sauton medium but liquid 7H9 and solid 7H11 Middlebrook media to culture Mtb, and they found no differences in mycolic acid composition between the WT and the mutant, which is in accordance with our observation for the BCG Dcpn60.1 mutant cultured in 7H9 medium.
The BCG Dcpn60.1 mutant had a higher protein content in its culture filtrate, and at the same time it had fewer proteins in its OMCE compared with the two other strains, suggesting that the cell wall of the mutant is probably impaired, resulting in a less stable anchoring of certain surface proteins that are consequently released into the culture medium. This release did not result in/from the cell lysis because all the tested bacteria had similar homeostasis, and enzymic assays showed no leakage of isocitrate dehydrogenase, an intracellular enzyme. 2-DE/MS analysis revealed a number of changes in protein composition of the mutant culture filtrate (Supplementary Material). For example, Cpn60.2 (GroEL-2), which is localized on the mycobacterial surface where it facilitates efficient bacterial association with macrophages (Hickey et al., 2009) , was found to be particularly abundant in the CF of the Dcpn60.1 mutant, while it was almost absent in the CF of the WT BCG. Two elongation factors EF-Tu and EF-Ts were also present in increased amounts in the CF of the mutant. These proteins are often observed in the CF when bacteria are stressed Mollenkopf et al., 1999) . Our data could therefore suggest that lack of Cpn60.1 resulted in a sustained stress-like state of the BCG bacteria. In line with this hypothesis, ICL, a key enzyme of the glyoxylate pathway, was slightly more abundant in the CE of the Dcpn60.1 mutant. In anaerobic conditions and/or when encountering difficult environments, Mtb usually switch the TCA cycle to the glyoxylate metabolic pathway to conserve energy and to cope better with difficult situations (Gengenbacher et al., 2010 ). An increase of ICL has been considered as one of the markers for the non-replicating persistence of Mtb Mtb is exposed to various environmental and/or physiological stresses during growth in the host. When Mtb resides within a granulomatous lesion during persistent stages of Fig. 7 . Sensitivity of the Dcpn60.1 mutant to SDS and H 2 O 2 . Bacteria were grown in 7H9 Middlebrook medium to exponential phase for 7-8 days. SDS and H 2 O 2 were added to the cultures at final concentrations of 0.0025 % and 10 mM, respectively. c.f.u. counts were determined after 48 h of stress exposure. Results are expressed as the percent survival of the strain exposed to the stress compared to the same strain without treatment. The values reported are the mean±SD of three independent experiments. Statistical significance is indicated. infection, it may encounter stresses such as hypoxia, nutrient limitation, reactive oxygen and nitrogen intermediates, low pH, alveolar surfactants etc. (Manganelli et al., 2004 Roberts et al., 2004; Voskuil et al., 2003) , the SigE/ SigB regulon in response to cell surface stress (Fontán et al., 2009; Manganelli et al., 2001) , the SigF regulon in adaptation to stationary phase, heat and oxidative stress (Hümpel et al., 2010) , and sigJ that controls sensitivity of Mtb to hydrogen peroxide (Hu et al., 2004) . Thus, Mtb uses a variety of twocomponent regulatory systems and stress-responsive sigma factors in regulating bacterial interactions with the extracellular environment to adapt to stresses (Missiakas & Raina, 1998) . Another two-component regulatory system MprAB also participates in surface stress response by regulating expression of sigma factors SigB and SigE in Mtb (Donà et al., 2008; He et al., 2006) . In Corynebacterium glutamicum, the promoters of heat-shock protein genes cpn60.1, cpn10 and cpn60.2 are all recognized by the stress-responsive sigma factor SigH (Barreiro et al., 2004) . Although not formally proven, it is possible that the role BCG Cpn60.1 has in the response to H 2 O 2 stress could also be SigH-dependent. Hu et al. (2008) found that Cpn60.1 has a role in thermotolerance in Mtb when tested at 55 u C. We have not tested the BCG strains at this temperature since it is not really a physiological condition. At 42 u C, we could not demonstrate a protective role of Cpn60.1 against heat stress.
The Dcpn60.1 mutant of Mtb was previously reported to grow slightly slower than the WT strain in mouse lungs and spleen in early infection, but by 12 weeks the number of organisms in these tissues were equivalent (Hu et al., 2008) . In our experiments, the BCG Dcpn60.1, more susceptible to H 2 O 2 killing, showed a reduced in vivo persistence, particularly in lungs when compared with the WT and complemented strains. In spleen, bacteria persisted at a higher level, and differences between the mutant and WT strain were less pronounced. Although the mutant in M. bovis BCG persisted less effectively, the actual number of mutant bacteria present in the animals was apparently sufficient to induce a Th1 response comparable with that induced by WT BCG and mycobacteria-specific IFN-c responses were similar following vaccination with the two BCG strains. The Dcpn60.1 mutant also conferred equal protection against a challenge with Mtb as WT and complemented BCG, as indicated by similar reductions in the number of luminescent Mtb bacilli in spleen and lungs compared with unvaccinated mice. The comparable overall mycobacteria-specific IFN-c response induced with the Dcpn60.1 mutant, directed among others against the mycolyl-transferases Ag85A and Ag85B with well-known protective potential (Huygen et al., 1988 (Huygen et al., , 1996 Lozes et al., 1997; Munk et al., 1994) , may explain this observation. It should also be noted that the expression of antigens Ag85A and Ag85B was comparable for both the WT BCG and the Dcpn60.1 mutant, but that the Cpn60.2 was found remarkably more abundant in the CF of the mutant. Cpn60.2 (Hsp65) is another well-known immunodominant and protective antigen (Bonato et al., 1998; Thole et al., 1988) . Although we did not examine Cpn60.2-specific immune responses, it is possible that they were increased in mice vaccinated with the Dcpn60.1 mutant. This could be an additional reason why the protective potential of the mutant was not affected.
In conclusion, our results show that Cpn60.1, despite being a nonessential protein and lacking obvious vaccine potential, is necessary for the integrity of the bacterial cell wall of BCG, is involved in resistance to H 2 O 2 -induced stress and might have a regulatory role in the expression of ICL.
